Pediapharm (CVE:PDP) Shares Up 1.7%

Pediapharm Inc. (CVE:PDPGet Free Report) shot up 1.7% on Wednesday . The company traded as high as C$0.31 and last traded at C$0.30. 26,000 shares were traded during trading, a decline of 74% from the average session volume of 100,369 shares. The stock had previously closed at C$0.30.

Pediapharm Stock Performance

The company has a debt-to-equity ratio of 186.87, a quick ratio of 0.71 and a current ratio of 1.12. The firm has a 50 day moving average price of C$0.30 and a two-hundred day moving average price of C$0.30. The company has a market capitalization of C$66.36 million and a P/E ratio of -4.11.

About Pediapharm

(Get Free Report)

Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children.

Featured Articles

Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with's FREE daily email newsletter.